+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Possibility of Coagulation System Activation Determination with Tissue Factor in Pregnancy Complications



Possibility of Coagulation System Activation Determination with Tissue Factor in Pregnancy Complications



Clinical Laboratory 62(10): 1851-1856



In this part of the study, where we determined the causes of preeclampsia and other obstetric complications, we focused on the role of tissue factor (TF) in the activation of these pathophysiological processes. Recent findings attribute a significant part of the activation of coagulation creation of autoantibodies. Once this mechanism is activated, the antibodies induce expression of tissue factor (TF, CD142) on monocytes and vascular endothelial cells. We have proposed a monitor activation model of the coagulation system in preeclampsia and other pregnancy complications using TF expression on monocytes by flow cytometry and simultaneous determination the TF-induced thrombin generation in plasma. To determine expression of tissue factor (CD142) on monocytes, we proposed a method of multicolor flow cytometry using anti CD45 PerCP, anti CD14 APC, anti CD16b FITC, and anti CD142 PE antibodies and the corresponding isotype controls. We verified the model on patients with severe antiphospholipid syndrome, which is a high expression of antibodies, in particular against beta-2GPI. We demonstrated complete inhibition of TF expression on monocytes and a significant reduction of thrombin generation in plasma.

(PDF emailed within 1 workday: $29.90)

Accession: 060107844

Download citation: RISBibTeXText

PMID: 28164533


Related references

Role of tissue factor in pregnancy complications: crosstalk between coagulation and inflammation. Thrombosis Research 127 Suppl 3: S43-S46, 2011

Kinetics of the tissue factor dependent activation of coagulation factor ix and factor x in a bovine plasma system. Journal of Biological Chemistry 254(24): 12337-12345, 1979

Active site-inhibited coagulation factor VIIa blocks platelet activation, thrombin generation, and accumulation of platelet-bound factor X in a tissue factor-initiated system. Blood 86(10 SUPPL 1): 77A, 1995

Tissue factor accelerates the activation of coagulation factor viii the role of a bifunctional coagulation cofactor. Thrombosis Research 40(3): 351-358, 1985

The role of tissue factor and tissue factor pathway inhibitor in blood coagulation and in thrombotic complications. Kardiologia Polska 68(10): 1158-1162, 2011

Activation of factor VII bound to tissue factor: a key early step in the tissue factor pathway of blood coagulation. Proceedings of the National Academy of Sciences of the United States of America 85(18): 6687-6691, 1988

Activation of the contact system of coagulation by a monoclonal antibody directed against a neodeterminant in the heavy chain region of human coagulation factor XII (Hageman factor). Journal of Biological Chemistry 264(22): 12941-9, 1989

Purification and properties of an abnormal blood coagulation factor IX (factor IXBm)/kinetics of its inhibition of factor X activation by factor VII and bovine tissue factor. Thrombosis and Haemostasis 45(1): 55-59, 1981

First epidermal growth factor-like domain of human blood coagulation factor IX is required for its activation by factor VIIa/tissue factor but not by factor XIa. Proceedings of the National Academy of Sciences of the United States of America 91(9): 3574-3578, 1994

C1-inhibitor efficiently inhibits Escherichia coli-induced tissue factor mRNA up-regulation, monocyte tissue factor expression and coagulation activation in human whole blood. Clinical and Experimental Immunology 173(2): 217-229, 2013

Tissue factor and tissue factor pathway inhibitor: a potential role in pregnancy and obstetric vascular complications?. Clinica Chimica Acta; International Journal of Clinical Chemistry 372(1-2): 43-46, 2006

Determination of surface tissue factor thresholds that trigger coagulation at venous and arterial shear rates: amplification of 100 fM circulating tissue factor requires flow. Blood 111(7): 3507-3513, 2008

Plasma high density lipoproteins inhibit the activation of coagulation factor X by factor VIIa and tissue factor. Febs Letters 132(1): 37-40, 1981

The contributions of Ca2+, phospholipids and tissue-factor apoprotein to the activation of human blood-coagulation factor X by activated factor VII. Biochemical Journal 265(2): 327-336, 1990

Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proceedings of the National Academy of Sciences of the United States of America 74(12): 5260-5264, 1977